Your session is about to expire
← Back to Search
Integrated Stigma Reduction Interventions for HIV/AIDS
Study Summary
This trial will study the effects of different interventions on HIV viral suppression among 840 adolescents living with HIV. The investigators will test the effects of a group-based HIV stigma reduction intervention for educators, multiple family groups with HIV stigma reduction combined with family economic empowerment, or Bolstered Standard of Care.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I understand the study and am willing to complete it.I am on antiretroviral therapy.
- Group 1: Treatment Arm 1
- Group 2: Treatment Arm 2
- Group 3: Control Arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are any additional participants being sought for the trial?
"As of current, this clinical trial is open for enrollment. The first posting was made on March 15th 2022 and the latest update occurred June 4th 2022 as per data from clinicaltrials.gov."
What is the upper limit of participants in this experiment?
"Affirmative, according to clinicaltrials.gov this medical trial has a call for participants open and running. This research was first listed on March 15th 2022 and its most recent update was June 4th 2022; 840 patients are being recruited from 1 site."
Is this research study open to individuals 85 years or older?
"This trial is reaching out to individuals aged between 10 and 17."
For whom is this clinical research most advantageous?
"This clinical trial seeks to recruit 840 HIV-positive adolescents between 10 and 17 years of age, verifying their diagnosis with a medical report. Moreover, these individuals must be treated with antiretroviral therapy, enrolled in primary or secondary school programs requiring boarding accommodation. Furthermore, the caregivers of ALHIVs who agree to participate in this study are also eligible for inclusion as well as teachers, school nurses and administrators from target institutions consenting to take part on the research."
Share this study with friends
Copy Link
Messenger